MAR 2015 ARTICLE LIST >>
PharmaTutor (March- 2015)
Print-ISSN: 2394 - 6679
e-ISSN: 2347 - 7881
(Volume 3, Issue 3)
Received On: 10/12/2014; Accepted On: 21/12/2014; Published On: 01/03/2015
AUTHORS: Suresh Rewar1*, Bansal BK1, Singh CJ2, Sharma AK2
1Department of pharmaceutics, Arya College of Pharmacy, Jaipur, Rajasthan, India
2Department of Pharmacology, Arya College of Pharmacy, Jaipur, Rajasthan, India
*sureshrewar1990@gmail.com
ABSTRACT: Chronopharmaceutical drug delivery systems are gaining a lot of interest as they deliver the drug at the right site of action, right time and right amount, as per the pathophysiological needs of the diseases. These systems are basically time-controlled drug delivery systems in which the system controls the lag time independent of environmental factors like pH, enzymes, GIT motility, etc. These systems are designed for chronopharmacotherapy which is based on the circadian rhythm of the body. The effectiveness and toxicity of many drugs vary depending on dosing time associated with 24 hr. rhythms of biochemical, physiological and behavioral processes under the control of circadian clock. The chronobiology of the various common 24-hour BP profiles seen in hypertensive patients in relation to cardiovascular risk and end-organ injury and ultimately the control and normalization of abnormal BP throughout daytime activity and night time sleep. Chronopharmacotherapy provides a means of individualizing the treatment of hypertension according to the circadian BP profile of each patient, and constitutes a new option to optimize BP control and to reduce the risk of cardiovascular disease. Various latest and upcoming marketed technologies of Chronopharmaceutical drug delivery used in treatment of hypertension diseases like OROS®, CODAS®, CEFORM®, DIFFUCAPS®, PULSINCAP® etc.
How to cite this article: S Rewar, BK Bansal, CJ Singh, AK Sharma; Chronopharmacotherapy of Hypertension: Time-dependent effects of treatment on blood pressure; PharmaTutor; 2015; 3(3); 18-23
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Bussemer T. Otto L. Bodmeier R. et. al. pulsatile drug delivery systems. Crit. Rev. Ther. Drug Carrier Syst., 2001; 18(5): 433-458
2. Davis SS. Illum L. Drug delivery system for challenging molecules. Int J Pharm,1998; 176:1-8
3. Mandal A.S. et.al. Drug delivery system based on chronobiology-a review. J. Control. Release, 2010; 147(3): 314-325
4. Qi Liu. et al. A Novel MultiUnit Tablet for Treating Circadian Rhythm Diseases. AAPS Pharm SciTech., 2013; 14: 861-869
5. Youan B.C. Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery. Journal of Controlled Release, 2004; 98(3): 337-353
6. Naoto Burioka. Yasushi Fukuoka. Satoru Koyanagi. Masanori M. Asthma Chronopharmacotherapy and the molecular clock. Advanced Drug Delivery Reviews, 2010; 62: 946-955
7. Smolensky M.H. D’Alonzo G.E. Biologic rhythms and medicine. Am. J. Med.,1988; 85: 34-46
8. Rosenberg G.D. Simmons D.J. Rhythmic dentinogenesis in the rabbit incisor: circadian, ultradian and infradian periods. Calcif. Tissue Int., 2006; 32: 29-44
9. Tofler G.H. et. al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J. Med., 1987; 316: 1514-1518
10. Portaluppi F. Hermida R.C. Circadian rhythms in cardiac arrhythmias and opportunities for their chronotherapy. Adv. Drug Deliv. Rev., 2007; 59: 940-951
11. Kannel W.B. Castelli W.P. McNamara P.M. Sorlie P. Some factors affecting morbidity and mortality in hypertension. The Framingham study, Milbank Mem. Fund Q., 1969; 47: 116-142
12. Chobanian A.V. et. al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. The JNC 7 report, JAMA, 2003; 289: 2560-2572
13. Labrecque G. Belanger P.M. Biological rhythms in the absorption, distribution, metabolism and excretion of drugs. Pharmacol. Ther., 1991; 52: 95-107
14. Lin S.Y. Chronotherapeutic approach to design a thermoresponsive membrane for transdermal drug delivery. Curr. Drug Deliv., 2004; 1: 249-263
15. Ohdo S. Koyanagi S. Suyama H. Higuchi S. Aramaki H. Changing the dosing schedule minimizes the disruptive effects of interferon on clock function, Nat. Med., 2001; 7: 356-360
16. Hermida R.C. Ayala D.E. Fernandez J.R. Mojon A. Alonso I. Calvo C. modeling the circadian variability of ambulatorily monitored B.P. by multiplecomponent analysis. Chronobiol. Int., 2002; 19: 461-481
17. Smolensky M.H. Knowledge and attitudes of American physicians and public about medical chronobiology and chronotherapeutics. Chronobiol. Int., 1998; 15: 377-394
18. Hermida R.C. Calvo C. Ayala D.E. Mojon A. Lopez J.E. Relationship between physical activity and blood pressure in dipper and non dipper Hypertensive patients. J. Hypertens., 2002; 20: 1097-1104
19. Hermida R.C. et.al. Effects of time of day of treatment on ambulatory blood pressure pattern of patients with resistant hypertension. Hypertension, 2005; 46: 1053-1059
20. Cutler N.R. et. al. Placebo controlled evaluation of three doses of a controlled on set, extended release formulation of verapamil in the treatment of stable angina pectoris. Am. J. Cardiol., 1995; 75: 1102-1106
21. Gupta S.K. Yih B.M. Atkinson L. Longstreth J. The effect of food, time of dosing, and body position on the pharmacokinetics and pharmacodynamics of verapamil and norverapamil. J. Clin. Pharmacol., 1995; 35: 1083-1093
22. Jain Deepika et. al. Recent technologies in pulsatile drug delivery systems. Biomatter, 2011; 1(1): 57-65
23. bewellbuzz.com/body-buzz/circadian-rhythm-is-vital-to-health-and-happiness/ Body’s Natural Clock or Circadian Rhythm May Be a Key to Health and Happiness. Dec 4, 2013; Retrieved Nov 29, 2014
.png)
